O	0	7	Hypoxia	Hypoxia	NN	B-NP
O	7	8	-	-	HYPH	B-NP
O	8	17	inducible	inducible	JJ	I-NP
O	18	24	factor	factor	NN	I-NP
O	25	26	1	1	CD	I-NP
O	27	37	activation	activation	NN	I-NP
O	38	40	by	by	IN	B-PP
O	41	48	aerobic	aerobic	JJ	B-NP
O	49	59	glycolysis	glycolysis	NN	I-NP
O	60	70	implicates	implicate	VBZ	B-VP
O	71	74	the	the	DT	B-NP
O	75	82	Warburg	Warburg	NNP	I-NP
O	83	89	effect	effect	NN	I-NP
O	90	92	in	in	IN	B-PP
O	93	107	carcinogenesis	carcinogenesis	NN	B-NP
O	107	108	.	.	.	O

B-Cell	110	116	Cancer	Cancer	NN	B-NP
I-Cell	117	122	cells	cell	NNS	I-NP
O	123	130	display	display	VBP	B-VP
O	131	135	high	high	JJ	B-NP
O	136	141	rates	rate	NNS	I-NP
O	142	144	of	of	IN	B-PP
O	145	152	aerobic	aerobic	JJ	B-NP
O	153	163	glycolysis	glycolysis	NN	I-NP
O	163	164	,	,	,	O
O	165	166	a	a	DT	B-NP
O	167	177	phenomenon	phenomenon	NN	I-NP
O	178	183	known	know	VBN	B-VP
O	184	196	historically	historically	RB	B-ADVP
O	197	199	as	as	IN	B-SBAR
O	200	203	the	the	DT	B-NP
O	204	211	Warburg	Warburg	NNP	I-NP
O	212	218	effect	effect	NN	I-NP
O	218	219	.	.	.	O

O	220	227	Lactate	Lactate	NN	B-NP
O	228	231	and	and	CC	I-NP
O	232	240	pyruvate	pyruvate	NN	I-NP
O	240	241	,	,	,	O
O	242	245	the	the	DT	B-NP
O	246	249	end	end	NN	I-NP
O	250	258	products	product	NNS	I-NP
O	259	261	of	of	IN	B-PP
O	262	272	glycolysis	glycolysis	NN	B-NP
O	272	273	,	,	,	O
O	274	277	are	be	VBP	B-VP
O	278	284	highly	highly	RB	I-VP
O	285	293	produced	produce	VBN	I-VP
O	294	296	by	by	IN	B-PP
B-Cell	297	303	cancer	cancer	NN	B-NP
I-Cell	304	309	cells	cell	NNS	I-NP
O	310	314	even	even	RB	B-PP
O	315	317	in	in	IN	I-PP
O	318	321	the	the	DT	I-PP
O	322	330	presence	presence	NN	I-PP
O	331	333	of	of	IN	I-PP
O	334	340	oxygen	oxygen	NN	B-NP
O	340	341	.	.	.	O

O	342	349	Hypoxia	Hypoxia	NN	B-NP
O	349	350	-	-	HYPH	B-NP
O	350	357	induced	induce	VBN	I-NP
O	358	362	gene	gene	NN	I-NP
O	363	373	expression	expression	NN	I-NP
O	374	376	in	in	IN	B-PP
B-Cell	377	383	cancer	cancer	NN	B-NP
I-Cell	384	389	cells	cell	NNS	I-NP
O	390	393	has	have	VBZ	B-VP
O	394	398	been	be	VBN	I-VP
O	399	405	linked	link	VBN	I-VP
O	406	408	to	to	TO	B-PP
O	409	418	malignant	malignant	JJ	B-NP
O	419	433	transformation	transformation	NN	I-NP
O	433	434	.	.	.	O

O	435	439	Here	Here	RB	B-ADVP
O	440	442	we	we	PRP	B-NP
O	443	450	provide	provide	VBP	B-VP
O	451	459	evidence	evidence	NN	B-NP
O	460	464	that	that	IN	B-SBAR
O	465	472	lactate	lactate	NN	B-NP
O	473	476	and	and	CC	I-NP
O	477	485	pyruvate	pyruvate	NN	I-NP
O	486	494	regulate	regulate	VBP	B-VP
O	495	502	hypoxia	hypoxia	NN	B-NP
O	502	503	-	-	HYPH	B-NP
O	503	512	inducible	inducible	JJ	I-NP
O	513	517	gene	gene	NN	I-NP
O	518	528	expression	expression	NN	I-NP
O	529	542	independently	independently	RB	B-ADVP
O	543	545	of	of	IN	B-PP
O	546	553	hypoxia	hypoxia	NN	B-NP
O	554	556	by	by	IN	B-PP
O	557	568	stimulating	stimulate	VBG	B-VP
O	569	572	the	the	DT	B-NP
O	573	585	accumulation	accumulation	NN	I-NP
O	586	588	of	of	IN	B-PP
O	589	596	hypoxia	hypoxia	NN	B-NP
O	596	597	-	-	HYPH	B-NP
O	597	606	inducible	inducible	JJ	I-NP
O	607	613	Factor	Factor	NN	I-NP
O	614	620	1alpha	1alpha	NN	I-NP
O	621	622	(	(	(	O
O	622	625	HIF	HIF	NN	B-NP
O	625	626	-	-	HYPH	B-NP
O	626	632	1alpha	1alpha	NN	I-NP
O	632	633	)	)	)	O
O	633	634	.	.	.	O

O	635	637	In	In	IN	B-PP
O	638	643	human	human	JJ	B-NP
B-Cancer	644	651	gliomas	glioma	NNS	I-NP
O	652	655	and	and	CC	O
O	656	661	other	other	JJ	B-NP
B-Cell	662	668	cancer	cancer	NN	I-NP
I-Cell	669	673	cell	cell	NN	I-NP
I-Cell	674	679	lines	line	NNS	I-NP
O	679	680	,	,	,	O
O	681	684	the	the	DT	B-NP
O	685	697	accumulation	accumulation	NN	I-NP
O	698	700	of	of	IN	B-PP
O	701	704	HIF	HIF	NN	B-NP
O	704	705	-	-	HYPH	B-NP
O	705	711	1alpha	1alpha	NN	I-NP
O	712	719	protein	protein	NN	I-NP
O	720	725	under	under	IN	B-PP
O	726	733	aerobic	aerobic	JJ	B-NP
O	734	744	conditions	condition	NNS	I-NP
O	745	753	requires	require	VBZ	B-VP
O	754	757	the	the	DT	B-NP
O	758	768	metabolism	metabolism	NN	I-NP
O	769	771	of	of	IN	B-PP
O	772	779	glucose	glucose	NN	B-NP
O	780	782	to	to	TO	B-VP
O	783	791	pyruvate	pyruvate	VB	I-VP
O	792	796	that	that	WDT	B-NP
O	797	805	prevents	prevent	VBZ	B-VP
O	806	809	the	the	DT	B-NP
O	810	817	aerobic	aerobic	JJ	I-NP
O	818	829	degradation	degradation	NN	I-NP
O	830	832	of	of	IN	B-PP
O	833	836	HIF	HIF	NN	B-NP
O	836	837	-	-	HYPH	B-NP
O	837	843	1alpha	1alpha	NN	I-NP
O	844	851	protein	protein	NN	I-NP
O	851	852	,	,	,	O
O	853	862	activates	activate	VBZ	B-VP
O	863	866	HIF	HIF	NN	B-NP
O	866	867	-	-	HYPH	B-NP
O	867	868	1	1	CD	I-NP
O	869	872	DNA	DNA	NN	I-NP
O	873	880	binding	binding	NN	I-NP
O	881	889	activity	activity	NN	I-NP
O	889	890	,	,	,	O
O	891	894	and	and	CC	O
O	895	903	enhances	enhance	VBZ	B-VP
O	904	907	the	the	DT	B-NP
O	908	918	expression	expression	NN	I-NP
O	919	921	of	of	IN	B-PP
O	922	929	several	several	JJ	B-NP
O	930	933	HIF	HIF	NN	I-NP
O	933	934	-	-	HYPH	B-NP
O	934	935	1	1	CD	I-NP
O	935	936	-	-	HYPH	I-NP
O	936	945	activated	activate	VBN	I-NP
O	946	951	genes	gene	NNS	I-NP
O	952	961	including	include	VBG	B-PP
O	962	976	erythropoietin	erythropoietin	NN	B-NP
O	976	977	,	,	,	O
O	978	986	vascular	vascular	JJ	B-NP
O	987	998	endothelial	endothelial	JJ	I-NP
O	999	1005	growth	growth	NN	I-NP
O	1006	1012	factor	factor	NN	I-NP
O	1012	1013	,	,	,	O
O	1014	1021	glucose	glucose	NN	B-NP
O	1022	1033	transporter	transporter	NN	I-NP
O	1034	1035	3	3	CD	I-NP
O	1035	1036	,	,	,	O
O	1037	1040	and	and	CC	O
O	1041	1049	aldolase	aldolase	NN	B-NP
O	1050	1051	A	A	NN	I-NP
O	1051	1052	.	.	.	O

O	1053	1056	Our	Our	PRP$	B-NP
O	1057	1065	findings	finding	NNS	I-NP
O	1066	1073	support	support	VBP	B-VP
O	1074	1075	a	a	DT	B-NP
O	1076	1081	novel	novel	JJ	I-NP
O	1082	1086	role	role	NN	I-NP
O	1087	1090	for	for	IN	B-PP
O	1091	1099	pyruvate	pyruvate	NN	B-NP
O	1100	1102	in	in	IN	B-PP
O	1103	1112	metabolic	metabolic	JJ	B-NP
O	1113	1122	signaling	signaling	NN	I-NP
O	1123	1126	and	and	CC	O
O	1127	1134	suggest	suggest	VBP	B-VP
O	1135	1136	a	a	DT	B-NP
O	1137	1146	mechanism	mechanism	NN	I-NP
O	1147	1149	by	by	IN	B-PP
O	1150	1155	which	which	WDT	B-NP
O	1156	1160	high	high	JJ	B-NP
O	1161	1166	rates	rate	NNS	I-NP
O	1167	1169	of	of	IN	B-PP
O	1170	1177	aerobic	aerobic	JJ	B-NP
O	1178	1188	glycolysis	glycolysis	NN	I-NP
O	1189	1192	can	can	MD	B-VP
O	1193	1200	promote	promote	VB	I-VP
O	1201	1204	the	the	DT	B-NP
O	1205	1214	malignant	malignant	JJ	I-NP
O	1215	1229	transformation	transformation	NN	I-NP
O	1230	1233	and	and	CC	I-NP
O	1234	1242	survival	survival	NN	I-NP
O	1243	1245	of	of	IN	B-PP
B-Cell	1246	1252	cancer	cancer	NN	B-NP
I-Cell	1253	1258	cells	cell	NNS	I-NP
O	1258	1259	.	.	.	O

